The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Medicamen Biotech Ltd. Share Price
Medicamen Biotech Ltd. (INR)492.620.7 (4.4%) 
Exchange ScripsBSE531146NSEMEDICAMEQISININE646B01010
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Medicamen Biotech Ltd. Performance
Market performance
Open price476
High498.9
Volumes107982
Prev Close492.6
Low466
Closing date2025-03-21
Historical performance
1 Year High630.00
3 Year High1225.00
5 Year High1225.00
1 Year Low375.05
3 Year Low355.45
5 Year Low355.45
Medicamen Biotech Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
618
Face Value (₹)
10
P/E Ratio
65.97
Dividend Yield
0.02 %
Medicamen Biotech Ltd. Investment Returns
1 Year
21.3%
3 Years
-28.6%
5 Years
N/A
10 Years
N/A
Medicamen Biotech Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 446.02 | Bullish |
| 10-DMA | 444.96 | Bullish |
| 20-DMA | 477.85 | Bullish |
| 50-DMA | 477.16 | Bullish |
| 100-DMA | 494.67 | Bearish |
| 200-DMA | 481.49 | Bullish |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 1 | 1 | 1 | 1 | 2 |
| Public Investors | 10575 | 10791 | 10651 | 10638 | 10250 |
| Government | 1 | --- | --- | --- | --- |
Medicamen Biotech Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 23 | 25 | 17 | 8 |
| Operating Profit | 258 | 268 | 258 | 204 |
| Interest | 57 | 34 | 19 | 15 |
| Depreciation | 71 | 64 | 58 | 25 |
| Profit Before Tax | 131 | 170 | 181 | 164 |
| Consolidated Net Profit | 95 | 147 | 149 | 121 |
| Adjusted EPS | 7 | 12 | 12 | 10 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 127 | 127 | 122 | 122 |
| Total Reserves | 1943 | 1782 | 1343 | 1207 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 5 | 7 | 60 | 78 |
| Total Liabilities | 2920 | 2766 | 2252 | 1940 |
| Capital Work in Progress | --- | --- | --- | --- |
| Total Assets | 2920 | 2766 | 2252 | 1940 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | -67 | -63 | 41 | 128 |
| Cash Flow from Investing Activities | -56 | -59 | -85 | -178 |
| Cash Flow from Financing Activitie | 63 | 291 | 43 | 58 |
| Net Cash Inflow / Outflow | -60 | 170 | -1 | 8 |
13%
Negative
Neutral
Positive
- The stock has a PE ratio of 65.97.
- 3Y Stock Price CAGR of the stock is -10.0.
- The stock has a beta of 1.6.
- In the last financial year, the company had an EBITDA of ₹258 Million.
- The company generated revenue of ₹1793 Million in the previous financial year.
Medicamen Biotech Ltd.
492.620.7 (4.4%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1228428.9
No. of Shares: 2493.8
Performance:22.8%
P/L: ₹228428.9
Top Gainers
Similar stocks
Announcing Stock of the Month!
